HLB Genex, Inc. (KOSDAQ:187420)

HLB Genex Statistics

Total Valuation

HLB Genex has a market cap or net worth of KRW 97.02 billion. The enterprise value is 97.22 billion.

Market Cap	97.02B
Enterprise Value	97.22B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

HLB Genex has 29.14 million shares outstanding. The number of shares has increased by 17.37% in one year.

Current Share Class	29.14M
Shares Outstanding	29.14M
Shares Change (YoY)	+17.37%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	12.56%
Owned by Institutions (%)	2.24%
Float	18.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.43
PB Ratio	2.04
P/TBV Ratio	3.48
P/FCF Ratio	46.60
P/OCF Ratio	35.83
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.42, with an EV/FCF ratio of 46.70.

EV / Earnings	-1,004.36
EV / Sales	2.44
EV / EBITDA	18.42
EV / EBIT	115.43
EV / FCF	46.70

Financial Position

The company has a current ratio of 0.94, with a Debt / Equity ratio of 0.87.

Current Ratio	0.94
Quick Ratio	0.82
Debt / Equity	0.87
Debt / EBITDA	7.90
Debt / FCF	19.85
Interest Coverage	0.11

Financial Efficiency

Return on equity (ROE) is 2.35% and return on invested capital (ROIC) is 0.62%.

Return on Equity (ROE)	2.35%
Return on Assets (ROA)	0.47%
Return on Invested Capital (ROIC)	0.62%
Return on Capital Employed (ROCE)	1.19%
Revenue Per Employee	532.19M
Profits Per Employee	-1.29M
Employee Count	75
Asset Turnover	0.38
Inventory Turnover	3.95

Taxes

In the past 12 months, HLB Genex has paid 1.10 billion in taxes.

Income Tax	1.10B
Effective Tax Rate	54.87%

Stock Price Statistics

The stock price has decreased by -1.77% in the last 52 weeks. The beta is -0.18, so HLB Genex's price volatility has been lower than the market average.

Beta (5Y)	-0.18
52-Week Price Change	-1.77%
50-Day Moving Average	3,162.30
200-Day Moving Average	3,743.33
Relative Strength Index (RSI)	59.19
Average Volume (20 Days)	47,547

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HLB Genex had revenue of KRW 39.91 billion and -96.80 million in losses. Loss per share was -3.79.

Revenue	39.91B
Gross Profit	15.71B
Operating Income	793.33M
Pretax Income	2.00B
Net Income	-96.80M
EBITDA	5.23B
EBIT	793.33M
Loss Per Share	-3.79

Balance Sheet

The company has 47.82 billion in cash and 41.32 billion in debt, giving a net cash position of 6.50 billion or 223.10 per share.

Cash & Cash Equivalents	47.82B
Total Debt	41.32B
Net Cash	6.50B
Net Cash Per Share	223.10
Equity (Book Value)	47.55B
Book Value Per Share	1,402.02
Working Capital	-4.40B

Cash Flow

In the last 12 months, operating cash flow was 2.71 billion and capital expenditures -626.05 million, giving a free cash flow of 2.08 billion.

Operating Cash Flow	2.71B
Capital Expenditures	-626.05M
Free Cash Flow	2.08B
FCF Per Share	71.46

Margins

Gross margin is 39.37%, with operating and profit margins of 1.99% and -0.24%.

Gross Margin	39.37%
Operating Margin	1.99%
Pretax Margin	5.02%
Profit Margin	-0.24%
EBITDA Margin	13.10%
EBIT Margin	1.99%
FCF Margin	5.22%

Dividends & Yields

HLB Genex does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.37%
Shareholder Yield	n/a
Earnings Yield	-0.10%
FCF Yield	2.15%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 19, 2018. It was a forward split with a ratio of 2.

Last Split Date	Mar 19, 2018
Split Type	Forward
Split Ratio	2

Scores

HLB Genex has an Altman Z-Score of 0.95 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.95
Piotroski F-Score	7